Assignee
NEWRON PHARM SPA
IT·24 granted patents·9 pending applications·94 citations·filing 1998–2025
Top patents by PatentIndex Score
33 records- 0182US6306903B1Alpha-aminoamide derivatives useful as analgesic agentsNEWRON PHARM SPA·Filed 1998·Granted Oct 23, 2001·50 cites·12 claims
- 0280US7855227B22-phenylethylamino derivatives as calcium and/or sodium channel modulatorsNEWRON PHARM SPA·Filed 2006·Granted Dec 21, 2010·4 cites·14 claims
- 0377US7718815B2Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disordersNEWRON PHARM SPA·Filed 2005·Granted May 18, 2010·4 cites·3 claims
- 0473US9492410B2Methods for treatment of Parkinson's diseaseNEWRON PHARM SPA·Filed 2014·Granted Nov 15, 2016·1 cites·16 claims
- 0565US6303819B1Substituted 2-benzylamino-2-phenyl-acetamide compoundsNEWRON PHARM SPA·Filed 1998·Granted Oct 16, 2001·21 cites·9 claims
- 0665US2025257031A1Process for the production of substituted 2-[2-(phenyl)ethylamino]alkaneamide derivativesNEWRON PHARM SPA·Filed 2025·Application pending·0 cites
- 0762US9248116B2Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsNEWRON PHARM SPA·Filed 2013·Granted Feb 2, 2016·0 cites·13 claims
- 0861US9051240B2Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsNEWRON PHARM SPA·Filed 2013·Granted Jun 9, 2015·0 cites·9 claims
- 0958US2010016440A1Alpha-aminoamide derivatives useful as anti-inflammatory agentsNEWRON PHARM SPA·Filed 2009·Application pending·0 cites
- 1057US9474738B2Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsNEWRON PHARM SPA·Filed 2015·Granted Oct 25, 2016·0 cites·8 claims
- 1157US9474739B2Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsNEWRON PHARM SPA·Filed 2015·Granted Oct 25, 2016·0 cites·8 claims
- 1256US9603832B2Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsNEWRON PHARM SPA·Filed 2015·Granted Mar 28, 2017·0 cites·9 claims
- 1356US9585869B2Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsNEWRON PHARM SPA·Filed 2015·Granted Mar 7, 2017·0 cites·15 claims
- 1456US9474737B2Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsNEWRON PHARM SPA·Filed 2015·Granted Oct 25, 2016·0 cites·7 claims
- 1555US12291495B2Process for the production of substituted 2-[2-(phenyl)ethylamino] alkaneamide derivativesNEWRON PHARM SPA·Filed 2020·Granted May 6, 2025·0 cites·20 claims
- 1654USRE40259EAlpha-aminoamide derivatives useful as analgesic agentsNEWRON PHARM SPA·Filed 1998·Granted Apr 22, 2008·14 cites·113 claims
- 1750US8846763B2High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereofNEWRON PHARM SPA·Filed 2013·Granted Sep 30, 2014·0 cites·40 claims
- 1850US7968592B23-aminopyrrolidone derivativesNEWRON PHARM SPA·Filed 2004·Granted Jun 28, 2011·0 cites·2 claims
- 1949US8697738B2Alpha-aminoamide derivatives useful in the treatment of addictive disordersNEWRON PHARM SPA·Filed 2013·Granted Apr 15, 2014·0 cites·6 claims
- 2048US7763751B2Hydroxylamine derivativesNEWRON PHARM SPA·Filed 2004·Granted Jul 27, 2010·0 cites·3 claims
- 2148US7709523B2Alpha-aminoamide derivatives useful as antimigraine agentsNEWRON PHARM SPA·Filed 2003·Granted May 4, 2010·0 cites·16 claims
- 2248US2008096965A1(Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective ModulatorsNEWRON PHARM SPA·Filed 2005·Application pending·0 cites
- 2346US9856207B2Process for the production of ralfinamide salts substantially free from impurities having genotoxic effectsNEWRON PHARM SPA·Filed 2016·Granted Jan 2, 2018·0 cites·28 claims
- 2446US7649005B2Substituted benzylaminoalkylene heterocyclesNEWRON PHARM SPA·Filed 2004·Granted Jan 19, 2010·0 cites·6 claims
- 2546US2016332959A1Fluorinated arylalkylaminocarboxamide derivativesNEWRON PHARM SPA·Filed 2016·Application pending·0 cites
- 2645US12134589B2Process for the production of substituted 2-[2-(phenyl) ethylaminojalkaneamide derivativesNEWRON PHARM SPA·Filed 2020·Granted Nov 5, 2024·0 cites·17 claims
- 2745US7411091B2N-acyl-N′-benzyl-alkylendiamino derivativesNEWRON PHARM SPA·Filed 2004·Granted Aug 12, 2008·0 cites·7 claims
- 2845US2007112025A1Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataractNEWRON PHARM SPA·Filed 2004·Application pending·0 cites
- 2943US7265244B2Cyclopentyl derivativesNEWRON PHARM SPA·Filed 2004·Granted Sep 4, 2007·0 cites·5 claims
- 3043US2011184068A1Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulatorsNEWRON PHARM SPA·Filed 2010·Application pending·0 cites
- 3140US2009005436A1Substituted Aminoalkyl- and Amidoalkyl-Benzopyran DerivativesNEWRON PHARM SPA·Filed 2006·Application pending·0 cites
- 3237US2010197799A1Hydroxylamine derivativesNEWRON PHARM SPA·Filed 2010·Application pending·0 cites
- 3336US2010267835A1Methods of treating disorders of trigeminalvascular activationNEWRON PHARM SPA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEWRON PHARM SPA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →